Literature DB >> 12869302

Expression profile of a gamma-deletion variant of the human telomerase reverse transcriptase gene.

Hisashi Hisatomi1, Kazuma Ohyashiki, Junko H Ohyashiki, Kumi Nagao, Taichi Kanamaru, Hiroyuki Hirata, Nozomu Hibi, Yutaka Tsukada.   

Abstract

The human telomerase reverse transcriptase (hTERT) is an essential component of the holoenzyme complex that adds telomeric repeats to the ends of chromosomes. The hTERT transcript has been shown to have two deletion type alternative splicing sites. One deletion site induces the alpha-deletion variant, lacking 36 bp from exon 6, and the other induces the beta-deletion variant, lacking 182 bp from exons 7 and 8. Here, we identified a novel deletion variant of the hTERT transcript in hepatocellular carcinoma cell lines. The deleted transcript was characterized by an in-frame deletion of 189 bp, spanning nucleotides 2710 to 2898, corresponding to the complete loss of exon 11 (gamma-deletion). The region lacking in the gamma-deletion lies within RT motifs D and E, suggesting that it is missing conserved residues from the catalytic core of the protein. Both gamma- and alpha-deletion variants were occasionally detected, but the beta-deletion variant was frequently observed. Our results may provide important information for more detailed studies on the regulation of telomerase activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869302      PMCID: PMC1502410          DOI: 10.1016/S1476-5586(03)80051-9

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  34 in total

1.  Alternative splicing of human genes: more the rule than the exception?

Authors:  J Hanke; D Brett; I Zastrow; A Aydin; S Delbrück; G Lehmann; F Luft; J Reich; P Bork
Journal:  Trends Genet       Date:  1999-10       Impact factor: 11.639

2.  Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium.

Authors:  G A Ulaner; J F Hu; T H Vu; H Oruganti; L C Giudice; A R Hoffman
Journal:  Int J Cancer       Date:  2000-02-01       Impact factor: 7.396

3.  Frequent alternative splicing of human genes.

Authors:  A A Mironov; J W Fickett; M S Gelfand
Journal:  Genome Res       Date:  1999-12       Impact factor: 9.043

Review 4.  Role of telomerase in cellular proliferation and cancer.

Authors:  S E Holt; J W Shay
Journal:  J Cell Physiol       Date:  1999-07       Impact factor: 6.384

5.  Clinical implications of telomerase activity in resected hepatocellular carcinoma.

Authors:  T Kanamaru; M Yamamoto; Y Morita; T Itoh; Y Kuroda; H Hisatomi
Journal:  Int J Mol Med       Date:  1999-09       Impact factor: 4.101

6.  Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT).

Authors:  M Wick; D Zubov; G Hagen
Journal:  Gene       Date:  1999-05-17       Impact factor: 3.688

7.  Human telomerase contains evolutionarily conserved catalytic and structural subunits.

Authors:  L Harrington; W Zhou; T McPhail; R Oulton; D S Yeung; V Mar; M B Bass; M O Robinson
Journal:  Genes Dev       Date:  1997-12-01       Impact factor: 11.361

Review 8.  Telomerase in human development and cancer.

Authors:  J W Shay
Journal:  J Cell Physiol       Date:  1997-11       Impact factor: 6.384

9.  Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.

Authors:  G A Ulaner; J F Hu; T H Vu; L C Giudice; A R Hoffman
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701

10.  Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer.

Authors:  H Ito; S Kyo; T Kanaya; M Takakura; M Inoue; M Namiki
Journal:  Clin Cancer Res       Date:  1998-07       Impact factor: 12.531

View more
  32 in total

Review 1.  The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance.

Authors:  Jonathan H Teichroeb; Joohwan Kim; Dean H Betts
Journal:  RNA Biol       Date:  2016-01-19       Impact factor: 4.652

Review 2.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

3.  Evolutionary conservation of alternative splicing in chicken.

Authors:  S Katyal; Z Gao; R-Z Liu; R Godbout
Journal:  Cytogenet Genome Res       Date:  2007       Impact factor: 1.636

4.  Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant.

Authors:  Lisa F Lincz; Lisa-Maree Mudge; Fiona E Scorgie; Jennette A Sakoff; Christopher S Hamilton; Michael Seldon
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

5.  Telomere length is related to alternative splice patterns of telomerase in thyroid tumors.

Authors:  Yongchun Wang; Alan K Meeker; Jeanne Kowalski; Hua-Ling Tsai; Helina Somervell; Christopher Heaphy; Lauren E Sangenario; Nijaguna Prasad; William H Westra; Martha A Zeiger; Christopher B Umbricht
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

6.  Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.

Authors:  Giuseppe Pelosi; Elisabetta Schianchi; Patrizia Dell'orto; Giulia Veronesi; Lorenzo Spaggiari; Felice Pasini; Gabriella Sozzi; Elisabeth Brambilla; Claudia Griso; Giuseppe Viale
Journal:  Virchows Arch       Date:  2005-09-29       Impact factor: 4.064

7.  Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing.

Authors:  Saravana P Selvanathan; Garrett T Graham; Hayriye V Erkizan; Uta Dirksen; Thanemozhi G Natarajan; Aleksandra Dakic; Songtao Yu; Xuefeng Liu; Michelle T Paulsen; Mats E Ljungman; Cathy H Wu; Elizabeth R Lawlor; Aykut Üren; Jeffrey A Toretsky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-03       Impact factor: 11.205

8.  Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms.

Authors:  Yongchun Wang; Jeanne Kowalski; Hua-Ling Tsai; Radharani Marik; Nijaguna Prasad; Helina Somervell; Pang-Kuo Lo; Lauren E Sangenario; Lars Dyrskjot; Torben F Orntoft; William H Westra; Alan K Meeker; James R Eshleman; Christopher B Umbricht; Martha A Zeiger
Journal:  Thyroid       Date:  2008-10       Impact factor: 6.568

9.  Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Henry R Bose
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

10.  Microenvironmental regulation of telomerase isoforms in human embryonic stem cells.

Authors:  Lida Radan; Chris S Hughes; Jonathan H Teichroeb; Flora M Vieira Zamora; Michael Jewer; Lynne-Marie Postovit; Dean Harvey Betts
Journal:  Stem Cells Dev       Date:  2014-06-17       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.